Key Developments For World Heart Corporation
World Heart Corporation (WHRT.O) (Consolidated Issue listed on NASDAQ Capital Market)
World Heart Corporation Signs Agreements For Minimally Invasive Blood Pump
World Heart Corporation announced that it has finalized assignment and exclusive license agreements with LaunchPoint Technologies Inc., (LPT) Goleta, California, and Carnegie Mellon University (CMU), Pittsburgh, Pennsylvania for its minimally invasive blood pump, the MiVAD. The MiVAD, is designed to provide partial cardiac support between 2-4 liters per minute to less sick heart failure patients than those served by existing full-support Left Ventricular Assist Devices (LVADs).
World Heart Corporation Receives IRB Approval At First Center In Levacor VAD BTT Clinical Trial
World Heart Corporation announced that Levacor Ventricular Assist Device (VAD) Bridge-to-Transplant (BTT) Study has been approved by the Institutional Review Board (IRB) at INTEGRIS Baptist Medical Center in Oklahoma City. On site clinical and technical training has been conducted, formally qualifying this center as the first for the Levacor Study.
World Heart Corporation Receives US Clinical Study Approval for the Levacor VAD
World Heart Corporation announced that it has received FDA conditional approval to begin a bridge-to-transplant (BTT) study of the Levacor Ventricular Assist Device (VAD) at ten US centers. The Company is required to provide some additional information to the FDA within 45 days, but the study is permitted to begin upon receipt of clinical center Institutional Review Board (IRB) approvals.
World Heart Corporation Appoints Morgan Brown As New Chief Financial Officer
World Heart Corporation announced that it has appointed Morgan Brown as Executive Vice President and Chief Financial Officer (CFO).
World Heart Corporation Appoints John Alexander Martin As New President and CEO
World Heart Corporation announced that it has appointed John Alexander (Alex) Martin as President and Chief Executive Officer(CEO). Mr. Martin also replaced Jal S. Jassawalla on the Board of Directors.
